tirzepatide osa fda approval The has expanded the of Eli Lilly's obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity — the first medication approved for the Weight-loss drug Zepbound resolves sleep

Updated May 16, 2026 Reviewed by Lybi Ma Key points GLP-1 receptor agonists arent just for diabetes or obesitythey may treat cannabis abuse disorder

This means that it helps healthy tissue heal but does not necessarily promote pathological growth

Already, Novo Nordisk is engaged in a patent dispute initiated by Huadong Medicine the pharmaceutical behemoth seeking to launch a Chinese rival to Ozempic

Exercises that work multiple muscle groups simultaneously (squats, deadlifts, bench press, rows, overhead press, lunges) recruit the most total muscle tissue per set

Lin, et al., 'Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids', Diabetes Obes

Your doctor can help you manage both medications in a way that supports your weight loss goals while keeping you healthy